| 產品名稱 |
Human adenovirus 3 |
| 商品貨號 |
B229347 |
| Classification |
Adenoviridae, Mastadenovirus, Human adenovirus B |
| Deposited As |
Adenovirus type 3 |
| Agent |
Human adenovirus 3 |
| Strain |
GB |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Not listed in NIAID catalog; presumed from nasal washings of adult male, common cold volunteer, Maryland, 1953 |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Comments |
Agglutinates rhesus RBC. Weakly oncogenic. This preparation (VR-847) derived from passage (replenishment) of VR-1080 (NIAID V203-001-014). REFERENCE STRAIN: Pereira, H.G. et al., Virology 20: 613, 1963. |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects in tissue culture CPE, fusing of cells and cell sloughing |
| Name of Depositor |
NIH/NIAID |
| Source |
Not listed in NIAID catalog; presumed from nasal washings of adult male, common cold volunteer, Maryland, 1953 |
| Year of Origin |
1953 |
| References |
Rowe WP, et al. Studies of the adenoidal-pharyngeal-conjunctival (APC) group of viruses. Am. J. Hyg. 61: 197-218, 1955.
Hierholzer JC, et al. Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera. Arch. Virol. 121: 179-197, 1991. PubMed: 1759904
|
